Eli Lilly’s CEO David Ricks could sign more deals to strengthen its pipeline of cancer drugs, but is leaving gene cell-based CAR-T oncology drugs and rare disease gene therapies for others to ...

Indiana Govenor Eric Holcomb appointed David A. Ricks to the Purdue University Board of Trustees to fill the vacancy created by the retirement of board chair Michael Berghoff effective January 2025.

That’s how much Eli Lilly’s revenue grew in 2024, but it was still not as much as the company or investors expected, which had CEO David Ricks trying to assuage investors. Lilly on Tuesday ...